Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 459-466 , July 2010

Nutritional recommendations for preventing coronary heart disease in women: Evidence concerning whole foods and supplements

  • S. Eilat-Adar

      Affiliations

    • MedStar Research Institute, 6495 New Hampshire Ave., Suite 201, Hyattsville, MD 20783, USA
    • Zinman College for Physical Education & Sports, Wingate Institute, Netanya 42902, Israel
    • Sackler Medical Faculty, Tel Aviv University, Tel Aviv 69978, Israel
    • Corresponding Author InformationCorresponding author at: 16 Zeira St., Tel Aviv 69624, Israel. Tel.: +972 3 647 6759; fax: +972 3 648 6451.
    • ,
  • U. Goldbourt

      Affiliations

    • Sackler Medical Faculty, Tel Aviv University, Tel Aviv 69978, Israel

Received 3 August 2009 ,Revised 14 January 2010 ,Accepted 18 January 2010.

References 

  1. Ferdinand KC. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol. 2006;97:12A–19A
  2. World Health Organization . Preventing chronic diseases: a vital investment. Available at: World Health Organization; 2009;http://www.who.int/features/factfiles/global_burden/en/index.html[accessed 12.02.09]
  3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–2497
  4. Willett WC. Diet and coronary heart disease. In:  Willett WC editors. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998;p. 414–466
  5. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006 a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96
  6. Eurodiet Core Report . Available at http://ec.europa.eu/health/ph_determinants/life_style/nutrition/report01_en.pdf&[accessed 28.02.09]
  7. Joint WHO/FAO Expert Consultation . Diet, nutrition and the prevention of chronic diseases. Available at Geneva, Switzerland: World Health Organization; 2003;http://www.who.int/hpr/NPH/docs/who_fao_expert_report.pdf[accessed 28.02.09]
  8. British Nutrition Foundation . Nutrient requirements and recommendations. Available at http://www.nutrition.org.uk/upload/CVD%20pdf%20for%20website.pdf[accessed 28.02.09]
  9. National Health and Medical Research Council . Nutrient reference values for Australia and New Zealand including recommended dietary intakes. Available at: http://www.nhmrc.gov.au/publications/synopses/n35syn.htm[accessed 20.12.08]
  10. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, et al. Diet and overall survival in elderly people. BMJ. 1995;311:1457–1460
  11. American Diabetes Association , Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl. 1):S61–S78
  12. Retelny VS, Neuendorf A, Roth JL. Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract. 2008;23:468–476
  13. Kelly SA, Summerbell CD, Brynes A, Whittaker V, Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev. 2007;18:CD005051
  14. Erkkilä AT, Lichtenstein AH. Fiber and cardiovascular disease risk: how strong is the evidence?. J Cardiovasc Nurs. 2006;21:3–8
  15. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006;136:2588–2593
  16. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655–666
  17. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–1899
  18. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–509
  19. Goldbourt U, Eilat Adar S. Omega-3 and CHD Risk. Harrison's Principles of Internal Medicine, 17e. http://www.accessmedicine.com/updatesContent.aspx?aid=10012752008;
  20. Kris-Etherton PM, Hu FB, Ros E, Sabaté J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138:1746S–1751S
  21. Food labeling: health claims: soy protein and coronary heart disease. Food and Drug Administration, HHS: final rule: soy protein and coronary heart disease. Fed Regist. 1999;64:57700–57733
  22. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006;113:1034–1044
  23. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965–978
  24. Patch CS, Tapsell LC, Williams PG, Gordon M. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence. Vasc Health Risk Manag. 2006;2:157–162
  25. Noakes M, Clifton P, Ntanios F, Shrapnel W, Record I, McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr. 2002;75:79–86
  26. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007176
  27. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123–2133
  28. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11:7–12
  29. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–854
  30. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730–1737
  31. Langman LJ, Cole DEC. Homocysteine. Crit Rev Clin Lab Sci. 1999;36:365–406
  32. Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G, et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med. 1999;131:321–330
  33. Dietrich M, Brown CJ, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr. 2005;24:266–274
  34. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164:1552–1556
  35. Bleys J, Miller ER, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006;84:880–887
  36. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004;19:380–389
  37. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84:762–773
  38. Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300:795–804
  39. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA. 2008;299:2027–2036
  40. Galan P, Briancon S, Blacher J, Czernichow S, Hercberg S. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics. Trials. 2008;9:35
  41. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–1588
  42. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–1577
  43. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–575
  44. Lange H, Suryapranata H, De Luca G, Börner C, Dille J, Kallmayer K, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004;350:2673–2681
  45. Liem AH, van Boven AJ, Veeger NJ, Withagen AJ, Robles de Medina RM, Tijssen JG, et al. Folic acid on risk diminishment after acute myocardial infarction study group. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol. 2004;93:175–179
  46. Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol. 2003;41:2105–2113
  47. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA. 2002;288:973–979
  48. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001;345:1593–1600

PII: S0939-4753(10)00020-7

doi: 10.1016/j.numecd.2010.01.011

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 459-466 , July 2010

Article Tools